Early report on the severity of COVID-19 in hematologic patients infected with the SARS-CoV2 omicron variant.

ABSTRACT:

Introduction

Patients with hematologic disease are at high risk of morbidity and mortality from COVID-19 due to disease-inherent and therapy-related immunodeficiency. Whether infection with the SARS-CoV2 omicron variant leads to attenuated disease severity in these patients is currently unknown.

Methods

We assessed clinical and laboratory parameters in 61 patients with underlying hematologic conditions with a SARS-CoV2 omicron variant infection confirmed by nucleic acid amplification testing.

Results

Fifty patients reported symptoms of COVID-19, most commonly fatigue (37 patients, 60.66%) and cough (32 patients, 52.46%). 39.34% of patients reported fever. Dyspnea was reported by 10 patients and 7 patients (11.48%) required oxygen therapy. Anosmia and ageusia were rela

SUBMITTER: Ullrich F 

PROVIDER: S-EPMC9350268 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature